The COVID-19 Saliva Collection Kits Market Is To Be Driven By Digitized Data Collection At A CAGR Of 3.9%

The COVID-19 Saliva Collection Kits Market Is To Be Driven By Digitized Data Collection At A CAGR Of 3.9%

COVID-19 Saliva Collection Kits Market

COVID-19 Saliva Collection Kits Market

Diagnostics to Dominate COVID-19 Saliva Collection Kits Market with Nearly Two-third Share: Persistence Market Research

PUNE, MAHARASHTRA, INDIA, May 6, 2022 /EINPresswire.com/ — The COVID-19 Saliva Collection Kits Market is slated to grow at a gracious rate of 3.9% by the year 2031. With a value-oriented approach being the need of the hour, the healthcare vertical is likely to go the technologically advanced way in the next 10 years. With Big Data, and AI comprising these advancements, the healthcare vertical is bound to create greater strides going forward.

As per Persistence Market Research’s latest industry analysis, the global COVID-19 saliva collection kits market was valued at US$ 189.8 Mn in 2020, and is expected to exhibit a CAGR of 3.9% over 2026-2031.

COVID-19 saliva collection kits are known as in-vitro diagnostic medical devices used for collecting biological samples for detecting the COVID-19 virus. Rising COVID-19 infections, focus on developing convenient kits, and increasing awareness on self-testing are primary factors that are expected to drive demand for COVID-19 saliva collection kits.

Increasing scales of COVID-19 diagnosing is anticipated to be an advantage for several medical technology players operating in the market. With respect to the pandemic, several diagnostic test manufacturers are concentrating on the development of easy-to-use and rapid POC COVID-19 diagnostic tests to help testing outside of laboratories.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32774

Key players are continuously focusing on expanding their product portfolios through the commercialization of products and launching of new products to grow their customer base and increase their sales footprint across countries.

In February 2021, Zymo Research announced its COVID-19 variant sequencing service. This new global service expanded Zymo Research’s end-to-end SARS-CoV-2 solutions that included sample collection, RNA extraction, and SARS-CoV-2 detection.

Psomagen, Inc., a CLIA-certified genetic analysis service provider, is adapting to the public’s changing COVID-19 testing needs by expanding its SARS-CoV-2 diagnostic services.
Company Profiles:

Thermo Fisher scientific
ACON Laboratories, Inc
KYODO INTERNATIONAL INC.
Lucence Health INc
Vitagene
Therma Bright Inc
Norgen Biotek Corp.
NeuMoDx Molecular, Inc.
Zymo Research Corporation.
Salimetrics
NEST Scientific USA
Mawi DNA Technologies

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/32774

Key Takeaways from Market Study

COVID-19 diagnostics is estimated to dominate the market by application. This segment accounted for approximately 63.9% share of the market in 2020.

Diagnostic laboratories dominated the landscape in 2020 with a market share of 27%. Growing number of advanced diagnostic centers and rise in number of rapid diagnostic testing are primary factors driving segment growth.

By region, Europe is set dominate the global COVID-19 saliva collection kits market with a value share of around 34.6% in 2021.
The U.S. dominated the market in the North American region with a value share of 67% in 2020.

In the East Asian region, China dominated the market with a share of 89% in 2020.

“Growing prevalence of COVID-19, preference toward convenient specimen testing, and new product launches beyond 2021 are expected to drive short-term market growth,” says an analyst of Persistence Market Research.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/32774

Market Competition

New product launches and approvals, agreements, collaborations, and partnerships have emerged as the key growth strategy adopted by industry players. By focusing on these strategies, key stakeholders are expanding their geographic footprints and strengthening their existing product portfolios.

In November 2020, to support large-scale research and surveillance programs, Thermo Fisher Scientific introduced the Thermo Scientific SpeciMAX saliva collection kit.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the COVID-19 saliva collection kits market in its latest study, presenting historical demand assessment of 2020 and projections for 2021 – 2031.

The research study is based on the application (COVID-19 research and COVID-19 diagnostics) and end user (diagnostic laboratories, hospitals & clinics, academic and research institutes, biopharma companies, long-term care facilities, home care settings, and others), across seven key regions of the world.

Rehabilitation Equipment Market-
The global rehabilitation equipment market is forecasted to reach a figure of about US$ 13,400 Mn in 2022 and is poised to exhibit a robust CAGR in the period of assessment.

Ventilator Test Systems Market-
As per PMR’s latest forecasts, the global ventilator test system market is estimated to touch a valuation of US$ 199.2 Mn with a healthy CAGR by 2026 end.

About us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics to helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]

Atul Singh
PMR
+1 646-568-7751
email us here
Visit us on social media:
Twitter
LinkedIn



Originally published at https://www.einpresswire.com/article/571382325/the-covid-19-saliva-collection-kits-market-is-to-be-driven-by-digitized-data-collection-at-a-cagr-of-3-9

The post The COVID-19 Saliva Collection Kits Market Is To Be Driven By Digitized Data Collection At A CAGR Of 3.9% first appeared on .

Health News - originally published at Health News -